Urology Research Center, School of Medicine, Razi hospital, Guilan University of Medical Sciences, Rasht, Iran.
Iran J Kidney Dis. 2020 Dec;14(6):439-447.
The main causes of death in kidney transplant recipients are cardiovascular diseases and malignancy. This study aimed to determine the types of post-transplant malignancy, incidence, and related factors in renal transplant recipients referred to Razi Hospital in Rasht, Iran.
This retrospective cross-sectional study was conducted on 549 kidney transplant recipients between 1998 and 2018. Patient-, transplant-, and medication-related factors and pathology reports were recorded in the check list. Chi-square, T-test and Logistic Regression were used to investigate the effect of variables. Malignancy-person-year incidence rate was calculated using survival tables and Kaplan-Mayer analysis.
43 (7.8%) recipients had malignancies. The most common site of malignancy was the skin (53.5%). Non-Melanoma Skin Cancer (NMSC) was the most common cancer (32.6%) followed by Kaposi sarcoma (20.9%). The standardized incidence ratio (SIR) of post-transplant malignancies in renal transplant recipients was 26.9 times the malignancies in Guilan province and 21.7 times the malignancies in Iran. Cox proportional hazard models identified older age at the time of transplantation and history of azathioprine consumption seems to be associated with risk for post-transplant malignancy.
The most common malignancies in these people were non-melanoma skin cancer, Kaposi sarcoma and then GI malignancies. According to the information obtained in this study, regular periodic examinations of kidney transplant recipients for early detection of malignancy is important.
肾移植受者的主要死亡原因是心血管疾病和恶性肿瘤。本研究旨在确定拉什特拉齐医院肾移植受者的移植后恶性肿瘤类型、发病率及相关因素。
本回顾性横断面研究于 1998 年至 2018 年期间对 549 名肾移植受者进行。在检查表中记录了患者、移植和药物相关因素以及病理报告。采用卡方检验、T 检验和逻辑回归分析变量的影响。使用生存表和 Kaplan-Meier 分析计算恶性肿瘤的人年发病率。
43 名(7.8%)受者患有恶性肿瘤。最常见的恶性肿瘤部位是皮肤(53.5%)。非黑素瘤皮肤癌(NMSC)是最常见的癌症(32.6%),其次是卡波西肉瘤(20.9%)。肾移植受者的移植后恶性肿瘤的标准化发病比(SIR)是古兰省恶性肿瘤的 26.9 倍,是伊朗恶性肿瘤的 21.7 倍。Cox 比例风险模型确定,移植时年龄较大和使用硫唑嘌呤的病史与移植后恶性肿瘤的风险相关。
这些患者中最常见的恶性肿瘤是非黑素瘤皮肤癌、卡波西肉瘤,然后是胃肠道恶性肿瘤。根据本研究获得的信息,定期对肾移植受者进行检查以早期发现恶性肿瘤非常重要。